Data-driven precision medical services use big data, artificial intelligence and advanced analysis technology to provide patients with personalized services based on individual patients' genomic information, biomarkers, medical imaging and other multi-dimensional data, combined with clinical medical knowledge and medical experience. A medical model that provides specialized and precise prevention, diagnosis, treatment and rehabilitation services. By deeply mining patient data and medical knowledge, precision medical services can better understand individual patients' disease risks, etiological mechanisms, and treatment responses, thereby achieving individualized and customized medical plans and improving medical effects and patients' quality of life.

The global Data-Driven Precision Medical Service market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime's newest research report, the “Data-Driven Precision Medical Service Industry Forecast” looks at past sales and reviews total world Data-Driven Precision Medical Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Data-Driven Precision Medical Service sales for 2023 through 2029. With Data-Driven Precision Medical Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Data-Driven Precision Medical Service industry.

This Insight Report provides a comprehensive analysis of the global Data-Driven Precision Medical Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Data-Driven Precision Medical Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Data-Driven Precision Medical Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Data-Driven Precision Medical Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Data-Driven Precision Medical Service.

Data-driven precision medical services are a revolutionary innovation in the medical field. Through in-depth analysis of patients' individual data, including genomes, biomarkers, clinical records, etc., combined with advanced technologies such as artificial intelligence and machine learning, we provide patients with Personalized, accurate diagnosis, treatment and prevention solutions. This service model subverts the one-size-fits-all model of traditional medical care, provides patients with more precise and efficient medical care, and can significantly improve the success rate of disease treatment and patients' quality of life. It is a key step forward in the medical field.

This report presents a comprehensive overview, market shares, and growth opportunities of Data-Driven Precision Medical Service market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Cloud Based
• On-Premises

Segmentation by Application:

• Hospital
• Clinic
• Others

This report also splits the market by region:

• Americas
  • United States
  • Canada
  • Mexico
  • Brazil
• APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
• Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• 23andMe
• Tempus
• Foundation Medicine
• Flatiron Health
• IBM Watson Health
• DNAnexus
• Guardant Health